Related references
Note: Only part of the references are listed.A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up
Jacqueline Trouillas et al.
ACTA NEUROPATHOLOGICA (2013)
Aggressive Silent GH Pituitary Tumor Resistant to Multiple Treatments, Including Temozolomide
Marie Batisse et al.
CANCER INVESTIGATION (2013)
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
Albert Beckers et al.
ENDOCRINE REVIEWS (2013)
Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis
Thomas Cuny et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
DNA Mismatch Repair Protein (MSH6) Correlated With the Responses of Atypical Pituitary Adenomas and Pituitary Carcinomas to Temozolomide: The National Cooperative Study by the Japan Society for Hypothalamic and Pituitary Tumors
Toshio Hirohata et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Functional screen analysis reveals miR-26b and miR-128 as central regulators of pituitary somatomammotrophic tumor growth through activation of the PTEN-AKT pathway
T. Palumbo et al.
ONCOGENE (2013)
Aggressive and malignant prolactin pituitary tumors: pathological diagnosis and patient management
Ilyess Zemmoura et al.
PITUITARY (2013)
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro
Giampaolo Trivellin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment
Melanie Philippon et al.
ANNALES D ENDOCRINOLOGIE (2012)
Treatment of nonfunctioning pituitary adenomas: What were the contributions of the last 10 years? A critical view
Alberto M. Pereira et al.
ANNALES D ENDOCRINOLOGIE (2012)
Subclinical hyperfunctioning pituitary adenomas: The silent tumors
Odelia Cooper et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Clinicopathological Correlations in Pituitary Adenomas
Ozgur Mete et al.
BRAIN PATHOLOGY (2012)
Endothelial Expression of Endocan Is Strongly Associated with Tumor Progression in Pituitary Adenoma
Aurelie Cornelius et al.
BRAIN PATHOLOGY (2012)
Pituitary carcinomas and aggressive pituitary tumours: merits and pitfalls of temozolomide treatment
Gerald Raverot et al.
CLINICAL ENDOCRINOLOGY (2012)
Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas
Cuong V Duong et al.
ENDOCRINE-RELATED CANCER (2012)
A classification tree approach for pituitary adenomas
Alberto Righi et al.
HUMAN PATHOLOGY (2012)
Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1
Daniela D'Angelo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway
Harvinder S. Chahal et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Towards an integrated molecular and clinical strategy to predict early recurrence in surgically resected non-functional pituitary adenomas
Nicholas F. Marko et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2012)
Downregulation of HMGA-targeting microRNAs has a critical role in human pituitary tumorigenesis
D. Palmieri et al.
ONCOGENE (2012)
Expression of cell growth negative regulators MEG3 and GADD45γ is lost in most sporadic human pituitary adenomas
Lisiane Cervieri Mezzomo et al.
PITUITARY (2012)
Anti-VEGF therapy in pituitary carcinoma
Leon D. Ortiz et al.
PITUITARY (2012)
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
Ferdinand Roelfsema et al.
PITUITARY (2012)
A miRNA Binding Site Single-Nucleotide Polymorphism in the 3′-UTR Region of the IL23R Gene Is Associated with Breast Cancer
Lihong Wang et al.
PLOS ONE (2012)
Silencing of the Imprinted DLK1-MEG3 Locus in Human Clinically Nonfunctioning Pituitary Adenomas
Pornsuk Cheunsuchon et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Treatment of Pituitary Neoplasms With Temozolomide A Review
Gianluca Marucci
CANCER (2011)
Expression and function of ErbB receptors and ligands in the pituitary
Odelia Cooper et al.
ENDOCRINE-RELATED CANCER (2011)
Identification of Growth Arrest and DNA-Damage-Inducible Gene β (GADD45β) as a Novel Tumor Suppressor in Pituitary Gonadotrope Tumors
Katherine A. Michaelis et al.
ENDOCRINOLOGY (2011)
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Ann I. McCormack et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
Pituitary Carcinoma with Malignant Growth from First Presentation and Fulminant Clinical Course-Case Report and Review of the Literature
Katarzyna Dudziak et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Pituitary Carcinoma: Difficult Diagnosis and Treatment
Anthony P. Heaney
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas
Hidenori Fukuoka et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Atypical pituitary adenomas: incidence, clinical characteristics, and implications Clinical article
Gabriel Zada et al.
JOURNAL OF NEUROSURGERY (2011)
HER2/ErbB2 Receptor Signaling in Rat and Human Prolactinoma Cells: Strategy for Targeted Prolactinoma Therapy
Hidenori Fukuoka et al.
MOLECULAR ENDOCRINOLOGY (2011)
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor
Marie S. Thearle et al.
PITUITARY (2011)
MicroRNA profile indicates downregulation of the TGFβ pathway in sporadic non-functioning pituitary adenomas
Henriett Butz et al.
PITUITARY (2011)
The Somatostatin Analogue Octreotide Confers Sensitivity to Rapamycin Treatment on Pituitary Tumor Cells
Vesna Cerovac et al.
CANCER RESEARCH (2010)
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
Alberto Fernandez et al.
CLINICAL ENDOCRINOLOGY (2010)
Differential expression of microRNAs in GH-secreting pituitary adenomas
Zhi-Gang Mao et al.
DIAGNOSTIC PATHOLOGY (2010)
Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis
Francoise Galland et al.
ENDOCRINE-RELATED CANCER (2010)
Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease
Gerald Raverot et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: experience in six cases
Marco Losa et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
SOM230 (Pasireotide) and Temozolomide Achieve Sustained Control of Tumour Progression and ACTH Secretion in Pituitary Carcinoma with Widespread Metastases
H. Bode et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
Maria Chiara Zatelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Prognostic Factors in Prolactin Pituitary Tumors: Clinical, Histological, and Molecular Data from a Series of 94 Patients with a Long Postoperative Follow-Up
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Down-Regulation of Wee1 Kinase by a Specific Subset of microRNA in Human Sporadic Pituitary Adenomas
Henriett Butz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Temozolomide Treatment in Aggressive Pituitary Tumors and Pituitary Carcinomas: A French Multicenter Experience
Gerald Raverot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The interperiosteo-dural concept applied to the perisellar compartment: a microanatomical and electron microscopic study
Patrick Francois et al.
JOURNAL OF NEUROSURGERY (2010)
Proliferation markers of human pituitary tumors: Contribution of a genome-wide transcriptome approach
Anne Wierinckx et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Isolation and characterization of novel pituitary tumor related genes: A cDNA representational difference approach
Xun Zhang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Silent Corticogonadotroph Adenomas: Clinical and Cellular Characteristics and Long-Term Outcomes
Odelia Cooper et al.
Hormones & Cancer (2010)
MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and-493 in pituitary carcinomas
Gail Stilling et al.
ENDOCRINE (2010)
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours
Ann I. McCormack et al.
CLINICAL ENDOCRINOLOGY (2009)
Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
Alexander Gorshtein et al.
ENDOCRINE-RELATED CANCER (2009)
Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors
D. Dworakowska et al.
ENDOCRINE-RELATED CANCER (2009)
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications
Marie-Lise Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2009)
MicroRNAs Differentially Expressed in ACTH-Secreting Pituitary Tumors
Fernando Colbari Amaral et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Overexpression of HMGA2 relates to reduction of the let-7 and its relationship to clinicopathological features in pituitary adenomas
Zhi Rong Qian et al.
MODERN PATHOLOGY (2009)
Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): A case-control study in a series of 77 patients versus 2509 non-MEN1 patients
Jacqueline Trouillas et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2008)
Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands
George Vlotides et al.
CANCER RESEARCH (2008)
Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia
Xuegong Zhu et al.
CLINICAL CANCER RESEARCH (2008)
Clinicopathological features of growth hormone-producing pituitary adenomas: Difference among various types defined by cytokeratin distribution pattern including a transitional form
Abdulkader Obari et al.
ENDOCRINE PATHOLOGY (2008)
Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas
Roger Gejman et al.
HUMAN PATHOLOGY (2008)
Molecular pathogenesis of human prolactinomas identified by gene expression profiling, RT-qPCR, and proteomic analyses
Chheng-Orn Evans et al.
PITUITARY (2008)
Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas
W. Saeger et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
MGMT immunoexpression predicts responsiveness of pituitary tumors to temozolomide therapy
Kalman Kovacs et al.
ACTA NEUROPATHOLOGICA (2008)
A diagnostic marker set for invasion, proliferation, and aggressiveness of prolactin pituitary tumors
Anne Wierinckx et al.
ENDOCRINE-RELATED CANCER (2007)
Activation of p53 by MEG3 non-coding RNA
Yunli Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Relevance of Ki-67 and prognostic factors for recurrence/progression of gonadotropic adenomas after first surgery
S. Dubois et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly:: mutations are found in a subset of young patients with macroadenomas
Laure Cazabat et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors
Sara Ekeblad et al.
CLINICAL CANCER RESEARCH (2007)
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas
Arianna Bottoni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Pathohistological classification of pituitary tumors:: 10 years of experience with the German Pituitary Tumor Registry
Wolfgang Saeger et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics
Alper Gurlek et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
TNM staging of foregut (neuro)endocrine tumors:: a consensus proposal including a grading system
G. Rindi et al.
VIRCHOWS ARCHIV (2006)
Long-term response of pituitary carcinoma to temozolomide - Report of two cases
Camilo E. Fadul et al.
JOURNAL OF NEUROSURGERY (2006)
Pituitary adenoma predisposition caused by germline mutations in the AIP gene
Outi Vierimaa et al.
SCIENCE (2006)
Pituitary tumours: findings from whole genome analyses
W. E. Farrell
ENDOCRINE-RELATED CANCER (2006)
Comments on the WHO 2004 classification of pituitary tumors
S Wolfsberger et al.
ACTA NEUROPATHOLOGICA (2006)
The new WHO classification of pituitary tumors: highlights and areas of controversy
ER Laws et al.
ACTA NEUROPATHOLOGICA (2006)
The 2004 World health organization classification of pituitary tumors: is it clinically helpful?
AB Grossman
ACTA NEUROPATHOLOGICA (2006)
The new WHO classification of human pituitary tumors: comments
D Figarella-Branger et al.
ACTA NEUROPATHOLOGICA (2006)
Novel molecular signaling and classification of human clinically nonfunctional pituitary adenomas identified by gene expression profiling and proteomic analyses
CS Moreno et al.
CANCER RESEARCH (2005)
Silent adenoma subtype 3 of the pituitary - Immunohistochemical and ultrastructural classification: A review of 29 cases
E Horvath et al.
ULTRASTRUCTURAL PATHOLOGY (2005)
miR-15a and miR-16-1 down-regulation in pituitary adenomas
A Bottoni et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Differential gene expression in pituitary adenomas by oligonucleotide array analysis
DG Morris et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization
SD Pack et al.
GENES CHROMOSOMES & CANCER (2005)
Clinical review: Diagnosis and management of pituitary carcinomas
GA Kaltsas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors
J Zhao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation
A Bahar et al.
ONCOGENE (2004)
Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia
S Ezzat et al.
MOLECULAR ENDOCRINOLOGY (2004)
Differential regulation of proopiomelanocortin and pituitary-restricted transcription factor (TPIT), a new marker of normal and adenomatous human corticotrophs
S Vallette-Kasic et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Polysialylated neural cell adhesion molecules expressed in human pituitary tumors and related to extrasellar invasion
J Trouillas et al.
JOURNAL OF NEUROSURGERY (2003)
A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells
X Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Pituitary disease in MEN type 1 (MEN1):: Data from the France-Belgium MEN1 multicenter study
B Vergès et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery
BP Meij et al.
JOURNAL OF NEUROSURGERY (2002)
Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: Implications for tumorigenesis
X Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Increased chromosomal imbalances in recurrent pituitary adenomas
CH Rickert et al.
ACTA NEUROPATHOLOGICA (2001)
Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction
CO Evans et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Cavernous sinus invasion by pituitary adenoma: MR imaging
JP Cottier et al.
RADIOLOGY (2000)
Share Paper
